These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36202619)

  • 21. Implementation of a Prenatal Naloxone Distribution Program to Decrease Maternal Mortality from Opioid Overdose.
    Duska M; Goodman D
    Matern Child Health J; 2022 May; 26(5):985-993. PubMed ID: 35029805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emergency department naloxone distribution: a Rhode Island department of health, recovery community, and emergency department partnership to reduce opioid overdose deaths.
    Samuels E
    R I Med J (2013); 2014 Oct; 97(10):38-9. PubMed ID: 25271659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opioid Overdose Harm Prevention: The Role of the Nurse in Patient Education.
    Gilles S
    Nurs Clin North Am; 2022 Sep; 57(3):477-488. PubMed ID: 35985734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors for severe respiratory depression from prescription opioid overdose.
    Fox LM; Hoffman RS; Vlahov D; Manini AF
    Addiction; 2018 Jan; 113(1):59-66. PubMed ID: 28646524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. OVERDOSED ON OPIOIDS: A deadly opioid epidemic sweeping the country has lawmakers working hard to find solutions.
    Hoback J
    State Legis; 2016 Apr; 42(4):9-13. PubMed ID: 27071212
    [No Abstract]   [Full Text] [Related]  

  • 26. Expanding the accessibility of harm reduction services in the United States: Measuring the impact of an automated harm reduction dispensing machine.
    Arendt D
    J Am Pharm Assoc (2003); 2023; 63(1):309-316. PubMed ID: 36549931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combative Treatment for Carfentanil Epidemic.
    Konapur R; Searls N; Babcock CCK; Blough E; Patel I
    J Addict Nurs; 2019; 30(1):2-3. PubMed ID: 30829994
    [No Abstract]   [Full Text] [Related]  

  • 28. Targeted virtual opioid overdose education and naloxone distribution in overdose hotspots for older adults during COVID-19.
    Beiting KJ; Molony J; Ari M; Thompson K
    J Am Geriatr Soc; 2022 Nov; 70(11):E26-E29. PubMed ID: 36169217
    [No Abstract]   [Full Text] [Related]  

  • 29. Opioid Overdose Prevention Programs Providing Naloxone to Laypersons - United States, 2014.
    Wheeler E; Jones TS; Gilbert MK; Davidson PJ;
    MMWR Morb Mortal Wkly Rep; 2015 Jun; 64(23):631-5. PubMed ID: 26086633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Community-based opioid overdose prevention programs providing naloxone - United States, 2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Feb; 61(6):101-5. PubMed ID: 22337174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Opioid Crisis and the Physician's Role in Contributing to its Resolution: Step One--Prevention of Overdoses.
    Wolfe S; Bouffard DL; Modesto-Lowe V
    Conn Med; 2016; 80(6):325-34. PubMed ID: 27509638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trends in pharmacy-based dispensing of buprenorphine, extended-release naltrexone, and naloxone during the COVID-19 pandemic by age and sex - United States, March 2019 - December 2020.
    Cremer LJ; Board A; Guy GP; Schieber L; Asher A; Parker EM
    Drug Alcohol Depend; 2022 Mar; 232():109192. PubMed ID: 35065513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of opioid overdose: current approaches and recent advances.
    Britch SC; Walsh SL
    Psychopharmacology (Berl); 2022 Jul; 239(7):2063-2081. PubMed ID: 35385972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expanding Access to Naloxone: A Necessary Step to Curb the Opioid Epidemic.
    Houser R
    Disaster Med Public Health Prep; 2022 Sep; 17():e245. PubMed ID: 36172901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. U.S. Military veterans and the opioid overdose crisis: a review of risk factors and prevention efforts.
    Bennett AS; Guarino H; Britton PC; O'Brien-Mazza D; Cook SH; Taveras F; Cortez J; Elliott L
    Ann Med; 2022 Dec; 54(1):1826-1838. PubMed ID: 35792749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Personal experience and awareness of opioid overdose occurrence among peers and willingness to administer naloxone in South Africa: findings from a three-city pilot survey of homeless people who use drugs.
    Wilson M; Brumwell A; Stowe MJ; Shelly S; Scheibe A
    Harm Reduct J; 2022 Feb; 19(1):17. PubMed ID: 35148779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Naloxone Use by Emergency Medical Services During the COVID-19 Pandemic: A National Survey.
    Cone DC; Bogucki S; Burns K; D'Onofrio G; Hawk K; Joseph D; Fiellin DA
    J Addict Med; 2020 Dec; 14(6):e369-e371. PubMed ID: 33031212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association Between Increased Dispensing of Opioid Agonist Therapy Take-Home Doses and Opioid Overdose and Treatment Interruption and Discontinuation.
    Gomes T; Campbell TJ; Kitchen SA; Garg R; Bozinoff N; Men S; Tadrous M; Munro C; Antoniou T; Werb D; Wyman J
    JAMA; 2022 Mar; 327(9):846-855. PubMed ID: 35230394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. COVID-19 Could Change the Way We Respond to the Opioid Crisis-for the Better.
    Bao Y; Williams AR; Schackman BR
    Psychiatr Serv; 2020 Dec; 71(12):1214-1215. PubMed ID: 32781928
    [No Abstract]   [Full Text] [Related]  

  • 40. Naloxone dosing in the era of ultra-potent opioid overdoses: a systematic review.
    Moe J; Godwin J; Purssell R; O'Sullivan F; Hau JP; Purssell E; Curran J; Doyle-Waters MM; Brasher PMA; Buxton JA; Hohl CM
    CJEM; 2020 Mar; 22(2):178-186. PubMed ID: 31955714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.